GHRP-6 / 5 mg

Description

Classic ghrelin-mimicking peptide for GH signaling research

GHRP-6 is one of the original growth hormone–releasing peptides. It’s widely studied for how it stimulates growth hormone release through the ghrelin receptor, making it a common reference point when comparing newer GH-related compounds.
In research settings, it’s often used to observe how the body’s GH pulses respond to stimulation, especially alongside compounds like CJC-1295 or Tesamorelin. Compared to more selective peptides like Ipamorelin, GHRP-6 is known for its broader activity profile, which makes it useful in models that look at multiple hormone pathways at once.
Because of this, GHRP-6 remains a baseline compound in GH-axis research—simple, well understood, and frequently used for comparison.

Research applications (investigational)

GHRP-6 has been investigated in experimental settings for its involvement in:

Ghrelin receptor (GHSR-1a) signaling pathways
Pulsatile growth hormone release mechanisms
GH/IGF-1 axis modulation research
Hypothalamic–pituitary endocrine pathway models
Appetite signaling and feeding behavior models
Comparative analysis of GHRP-class compounds
Multi-pathway endocrine interaction studies

These areas reflect ongoing scientific investigation rather than established applications.

Product characteristics

Purity: ≥98% (HPLC-tested)
Appearance: Lyophilized white/off-white powder
Molecular formula: C₄₈H₅₉N₁₃O₇
Molecular weight: 930.06
Sequence: Gly-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Storage: store lyophilized powder at -20°C, protect from light and moisture. Reconstituted solution should be kept at 2–8°C and used within a short period.

Why choose our GHRP-6?

≥ 98% purity verified by HPLC.
Produced in GMP-compliant facilities under strict QC protocols.
Each batch carefully lab tested after production (you can find Certificate of Analysis under product pictures).
Freeze-dried (lyophilized) for maximum stability and extended shelf life.
Sealed in sterile vials, ready for reconstitution.
Compatible with standard peptide reconstitution protocols using bacteriostatic water

Selected research references

• Bowers CY et al. “Structure-activity relationships of growth hormone–releasing peptides.” Endocrinology, 1990.
• Smith RG et al. “Growth hormone secretagogues: physiology and clinical relevance.” Trends in Endocrinology & Metabolism, 2005.
• Kojima M et al. “Ghrelin is a growth-hormone-releasing acylated peptide.” Nature, 1999.
• Arvat E et al. “GHRP-2 and endocrine responses in humans.” Journal of Endocrinological Investigation, 1997.
• Clinical research literature investigating ghrelin receptor agonists and GH-axis signaling pathways.

Related research context

GHRP-6 belongs to the growth hormone secretagogue class, a group of peptides studied for their role in GH signaling, endocrine modulation, and pulsatile hormone release.
Researchers studying GH-axis dynamics may also examine:

Ipamorelin – selective GH-releasing peptide
CJC-1295 (no DAC) – short-acting GHRH analogue
Tesamorelin – GHRH-based peptide analogue
GHRP-2 – strong GH-releasing peptide

Browse all compounds in the Growth hormone secretagogues category or explore broader endocrine signaling pathways in the Growth hormone peptides research guide.

NOTE: This is for educational reference only and does not constitute medical advice.

Disclaimer:
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.